Wednesday, 3 June 2020

India approves Gilead's remdesivir to treat severe COVID-19 cases

India's government has approved Gilead Sciences Inc's antiviral drug remdesivir for emergency use for five doses in treating COVID-19 patients.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)